HLAMatchmaker: A Molecularly Based Algorithm for Histocompatibility Determination. V. Eplet Matching for HLA-DR, HLA-DQ, and HLA-DP

Human Immunology

Volumn 68, Issue 1, 2007, Pages 12-25

  Duquesnoy, Rene J ^a   Askar, Medhat ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

epitope structure; eplet; histocompatibility; HLA; HLAMatchmaker

Indexed keywords

HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALGORITHM; AMINO ACID SEQUENCE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CROSS REACTION; GENETIC POLYMORPHISM; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MOLECULAR MODEL; PRIORITY JOURNAL;

ALGORITHMS; COMPUTATIONAL BIOLOGY; EPITOPES; HISTOCOMPATIBILITY TESTING; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS;

EID: 33845877696     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.10.003     Document Type: Article

References (66)

1. Schoenemann C., Groth J., Leverenz S., and May G. HLA class I and class II antibodies: monitoring before and after kidney transplantation. Transplantation 65 (1998) 1519
2. Mahoney R.J., Taranto S., and Edwards E. B-Cell Crossmatching and kidney allograft outcome in 9031 United States transplant recipients. Hum Immunol 63 (2002) 324
3. Gebel H., Bray R., and Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Amer J Transplant 3 (2003) 1488
4. Iniotaki-Theodoraki A.G., Boletis J.N., Trigas G., Kalogeropoulou H.G., Kostakis A.G., and Stavropoulos-Giokas C.G. Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period. Transplantation 75 (2003) 1601
5. Itescu S., Tung T.C., Burke E.M., Weinberg A., Moazami N., Artrip J.H., Suciu-Foca N., Rose E.A., Oz M.C., and Michler R.E. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98 (1998) 786
6. McKenna R.M., Takemoto S., and Terasaki P.I. Anti-HLA antibodies after solid organ transplantation. Transplantation 69 (2000) 319
7. Terasaki P.I. Humoral theory of transplantation. Amer J Transplant 3 (2003) 665
8. Duquesnoy R.J., Annen K., Marrari M., and Kauffman Jr. H.M. Association of MB compatibility with successful intrafamilial kidney transplantation. N Engl J Med 302 (1980) 821
9. Matsuno N., Hidetoshi I., Ando A.T.N., Sato T., Ichikawa S., Sonoda T., and Tsuji K. Importance of DQB as indicator in living related kidney transplant. Transplantation 49 (1990) 208
10. Tong J.Y., Hsia S., Parris G.L., Nghiem D.D., Cottington E.M., Rudert W.A., and Trucco M. Molecular compatibility and renal graft survival-the HLA DQB1 genotyping. Transplantation 55 (1993) 390
11. Middleton D., Mytilineos D., Savage D., Ferrara G.B., Angelini G., Ameroso A., Trainor F., Gaweco A., Mazzola G., Delfino L., Berrino M., and Oplez G. Matching for HLA-DPB1 alleles in zero mismatched HLA-A, -B and -DR Renal Transplants. Transpl Proc 24 (1992) 2439
12. Mytilineos J., Deufel A., and Opelz G. Clinical relevance of HLA-DPB locus matching for cadaver kidney retransplants: a report of the Collaborative Transplant Study. Transplantation 63 (1997) 1351
13. Laux G., Mansmann U., Deufel A., and Opelz G. A new epitope-based HLA-DP matching approach for cadaveric kidney transplantation. Transplantation 75 (2003) 1527
14. Arnold M.-L., Pei R., Spriewald B., and Wassmuth R. Anti-HLA class II antibodies in kidney retransplant patients. Tissue Antigens 65 (2005) 370
15. Duquesnoy R.J. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 63 (2002) 339
16. Duquesnoy R.J., Takemoto S., De Lange P., Doxiadis I.I.N., Schreuder G.M.T., and Claas F.H.J. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation 75 (2003) 884
17. Boehringer D., Reinhard T., Duquesnoy R., Boehringer S., Enczmann J., de Lange P., Claas F., and Sundmacher R. Beneficial effect of matching at the HLA-A and B amino-acid triplet level on rejection free survival in penetrating keratoplasty. Transplantation 77 (2004) 417
18. Laux G., Mytilineos J., and Opelz G. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation. Transplantation 77 (2004) 902
19. Duquesnoy R., and Claas F. Is the application of HLAMatchmaker relevant in kidney transplantation?. Transplantation 79 (2005) 250
20. Haririan A., Fagoaga O., Daneshvar H., Morawski K., Sillix D., El-Amm J., West M., Garnick J., Migdal S., Gruber S., and Nehlsen-Cannarella S. Predictive value of HLA epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort. Clin Transplant 20 (2006) 226
21. Duquesnoy R.J., and Marrari M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 63 (2002) 353
22. Lobashevsky A.L., Senkbeil R.W., Shoaf J.L., Stephenson A.K., Skelton S.B., Burke R.M., Deierhoi M.H., and Thomas J.M. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. Hum Immunol 63 (2002) 364
23. Dankers M.K.A., Witvliet M.D., Roelen D.L., De Lange P., Korfage N., Persijn G.G., Duquesnoy R.J., Doxiadis I.I.N., and Claas F.H.J. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched HLA antigens. Transplantation I28 (2004) 1236
24. Duquesnoy R.J., Witvliet M.J., Doxiadis I.I.N., de Fijter H., and Claas F.H.J. HLAMatchmaker-based strategy to identify acceptable HLA class i mismatches for highly sensitized kidney transplant candidates. Transpl Int 7 (2004) 31
25. Claas F.H.J., Witvliet M., Duquesnoy R.J., Persijn G., and Doxiadis I.I.N. The acceptable mismatch program as a fast tool to transplant highly sensitized patients awaiting a post-mortal kidney: short waiting time and excellent graft outcome. Transplantation 78 (2004) 190
26. Iniotaki-Theodoraki A., Kalogeropoulou E., Apostolaki M., Doxiadis I., and Stavropoulos-Giokas C. Humoral sensitization against rejected grafts: specific antibodies to graft immunogenic amino acid triplets. Transplant Proc 36 (2004) 1728
27. Varnavidou-Nicolaidou A., Doxiadis I., Iniotaki-Theodoraki A., Patargias T., Stavropoulos-Giokas C., and Kyriakides G. HLA class I donor-specific triplet antibodies detected after renal transplantation. Transplant Proc 36 (2004) 1732
28. Adeyi O., Girnita A., Awadalla Y., Askar M., Shapiro R., Howe J., Martell J., Zeevi A., Nalesnik M., Rhandawa P., Demetris A.J., and Duquesnoy R.J. Serum analysis after kidney transplant nephrectomy reveals restricted antibody specificity patterns against donor HLA class i antigens. Transpl Immunol 14 (2005) 53
29. Doxiadis I.I.N., Duquesnoy R.J., and Claas F.H.J. Extending options for highly sensitized patients to receive a suitable kidney graft. Curr Opin Immunol 17 (2005) 536
30. Goodman R., Taylor C., O'Rourke C., Lynch A., Bradley A., and Key K. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitised patients awaiting kidney transplantation. Transplantation 81 (2006) 1331
31. Nambiar A., Duquesnoy R.J., Adams S., Oblitas J., Leitman S., Stroncek D., and Marincola F. HLAMatchmaker-driven analysis of response to HLA matched platelet transfusions in alloimmunized patients. Blood 107 (2006) 1680
32. Duquesnoy R. A structurally based approach to determine HLA compatibility at the humoral immune level. Human Immunol 67 (2006) 847-862
33. Chen J., Anderson J.B., DeWeese-Scott C., Fedorova N.D., Geer L.Y., He S., Hurwitz D.I., Jackson J.D., Jacobs A.R., Lanczycki C.J., Liebert C.A., Lin C., Madej T., Marchler-Bauer A., Marchler G.H., Mazumder R., Nikolskaya A.N., Rao B.S., Panchenko A.R., Shoemaker B.A., Simonyan V., Song J.S., Thiessen P.A., Vasudevan S., Wang Y., Yamashita R.A., Yin J.J., and Bryant S.H. MMDB: Entrez's 3D-structure database. Nucleic Acids Res 31 (2003) 474
34. Hogue C. Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem Sci 22 (1997) 314
35. Mullen M.M., Haan K.M., Longnecker R., and Jardetzky T.S. Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell 9 (2002) 375
36. Ghosh P., Amaya M., Mellins E., and Wiley D.C. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378 (1995) 457
37. Bolin D.R., Swain A.L., Sarabu R., Berthel S.J., Gillespie P., Huby N.J., Makofske R., Orzechowski L., Perrotta A., Toth K., Cooper J.P., Jiang N., Falcioni F., Campbell R., Cox D., Gaizband D., Belunis C.J., Vidovic D., Ito K., Crowther R., Kammlott U., Zhang X., Palermo R., Weber D., Guenot J., Nagy Z., and Olson G.L. Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures. J Med Chem 43 (2001) 2135
38. Smith K.J., Pyrdol J., Gauthier L., Wiley D.C., and Wucherpfennig K.W. Crystal structure of HLA-DR2 (DRA1*0101,DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med 188 (1998) 1511
39. Lang H., Jacobsen H., Ikemizu S., Andersson C., Harlos K., Madsen L., Hjorth P., Sondergaard L., Svejgaard A., Wucherpfennig K., Stuart D., Bell J., Jones E.Y., and Fugger L. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3 (2002) 940
40. Kim C.Y., Quarsten H., Bergseng E., Khosla C., and Sollid L.M. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A 101 (2004) 4175
41. Lee K.H., Wucherpfennig K.W., and Wiley D.C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2 (2001) 501
42. Siebold C., Hansen B.E., Wyer J.R., Harlos K., Esnouf R.E., Svejgaard A., Bell J.I., Strominger J.L., Jones E.Y., and Fugger L. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A 101 (2004) 1999
43. Combet C., Jambon J., Deleage G., and Geourjon C. Geno3D: automatic comparative molecular modeling of protein. Bioinformatics 18 (2002) 213
44. Viken H.D., Paulsen G., Drover S., Marshall W.H., Sollid L.M., Gaudernack G., and Thorsby E. Influence on antibody recognition of amino acid substitutions in the cleft of HLA-DQ2 molecules. Suggestive evidence of peptide-dependent epitopes. Hum Immunol 44 (1995) 63
45. Smith K.D., Mace B.E., Valenzuela A., Vigna J.L., McCutcheon J.A., Barbosa J.A., Huczko E., Engelhard V.H., and Lutz C.T. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. J Immunol 157 (1996) 2470
46. Takamiya Y., Sakaguchi T., Miwa K., and Takiguchi M. Role of HLA-B*5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope. Int Immunol 8 (1996) 1027
47. Mulder M., Eijsink C., Kester M.G.D., Franke M.E.I., Kardol M.J., Heemskerk M.H.M., van Kooten C., Verreck F.A., Drijfhout J.W., Koning F., Doxiadis I.N., and Claas F.J.H. Impact of peptides on the recognition of HLA class i molecules by human HLA antibodies. J Immunol 175 (2005) 5950
48. Altschul S., Madden T., Schäffer A., Zhang J., Zhang Z., Miller W., and Lipman D. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25 (1997) 3389
49. Robinson J., Waller M., Parham P., de Groot N., Bontrop R., Kennedy L.J., Stoer P., and Marsh S.G. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 31 (2003) 311
50. Albert E.D., Baur M.P., and Mayr W.R. Histocompatibility Testing 1984. In Class II Antigen Reports (1984), Springer-Verlag, Berlin
51. In: Dupont B. (Ed). Immunobiology of HLA. In Histocompatibility Testing 1987 Vol. I (1987), Springer-Verlag, New York
52. In: Tjuji K., Aizawa M., and Sasazuki T. (Eds). HLA1991 Vol. 1 (1991), Oxford University Press, Oxford Proceedings of the Eleventh International Workshop and Conference
53. Charron D. Allele and Haplotype Society Reports #10-18 (1997), EDK Medical and Scientific International Publisher, Sevres In Proceedings of the Twelfth International Histocompatibility Workshop and Conference
54. Navarrete C., Brown C., De Lange P., and Schreuder G.M.T. 12th International Histocompatibility Workshop HLA Class II Monoclonal Antibodies Study. In: Charron D. (Ed). HLA Genetic Diversity of HLA. Functional and Medical Implication Vol. 1 (1997), EDK Publisher, Paris
55. Schreuder G.M.T. Serological Definition of HLA-DR and -DQ Polymorphisms (1989), CIP-Data Koninklijke Bibliotheek, The Hague
56. Duquesnoy R.J., Mulder A., Askar M., Fernandez-Vina M., and Claas F.H.J. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 66 (2005) 749
57. Fuggle S.V., Carter C., Watts F., Kirkley J., and Morris P.J. Monoclonal antibody definition of multiple polymorphic epitopes on HLA-DRw52. Human Immunol 19 (1987) 255
58. Taylor C.J., Ugozolli L., Tanigaki N., Tosi G., Bunce M., Ting A., and Ferrara G.B. Antigen Society #29 Report (DRw52). In: Dupont B. (Ed). Immunobiology of HLA. Vol. I. Histocompatibility Testing (1987), Springer Verlag, New York 273, 1987
59. Tongio M.M., van der Berg-Loonen E., Bignon J.D., Chandanayingyong D., Dormoy A., Eiermann T., Marshall W., Park M.S., and Scheuder G.M.T. HLA-DP Detected by Serology (1997), EDK Medical and Scientific International Publisher, Sevres
60. Fernandez-Vina M., Moraes J.R., Moraes M.E., Miller S., and Stastny P. HLA class II haplotypes in Amerindians and in black North and South Americans. Tissue Antigens 38 (1991) 235
61. Clayton J., Lonjou C., and Whittle D. DRB1-DQA1-DQB1 Haplotype Frequencies. In: Charron D. (Ed). HLA Genetic Diversity of HLA. Functional and Medical Implication (1997), EDK Publisher, Paris
62. Klitz W., Maiers M., Spellman S., Baxter-Lowe L.A., Schmeckpeper B., Williams T.M., and Fernandez-Vina M. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62 (2003) 296
63. Pfeffer K., Vogeler U., Albrecht K.H., Eigler F.W., Buchholz B., and Grosse-Wilde H. HLA-DP antibodies in patients awaiting renal transplantation. Transpl Internat 8 (1995) 180
64. Youngs D. DP alloantibodies. American Society for Histocompatibility and Immunogenetics Quarterly 2 (2004) 60
65. Qiu J., Cai J., Terasaki P.I., El-Awar N., and Lee J.H. Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads. Transplantation 80 (2005) 1511
66. Duquesnoy R.J., and Claas F.H.J. Progress report of 14th International Histocompatibility Workshop Project on the structural basis of HLA compatibility. Tissue Antigens (2006) In Press